Kernels from
As 2025 gets underway, Apriqot is building momentum with new projects, key hires, and exciting developments.
Our focus on producing meaningful, actionable public health insights continues to drive our work forward.
Here are the latest updates – kernels – from the Apriqot team.
New Projects
Producing Eligibility Estimates for Cancer
Screening Programs with the Maine CDC
We are thrilled to be deepening our relationship with the Maine CDC after successful completion of our Alzheimer's Disease and Related Dementias project in 2024
Apriqot is partnering with the Maine CDC to create small area estimates of under- and uninsured individuals eligible for cancer screening reimbursement. These estimates will support outreach for the Maine CDC’s Breast and Cervical Health and Colorectal Cancer Control programs, helping to ensure these critical services reach those in need.
Apriqot Platform Development
Using funding secured from our Maine Technology Institute Phase III grant, we are building an initial version of the Apriqot software platform.
*Disclaimer: Data is synthetic.
Project Updates
Medical Baseline Program Eligibility with California’s Investor-Owned Utilities
Big news for our Medical Baseline project: The investor-owned utilities have approved our study plan (accessible here) for producing eligibility estimates of customers with medical needs that qualify them for energy discounts.
Once the California Public Utility Commission approves the plan, we will move into the data collection and estimate development phases.
Mapping Food Insecurity in Southern Maine
with MaineHealth and the City of Portland
Our collaboration with MaineHealth and the City of Portland is beginning to deliver actionable insights into food insecurity in Southern Maine.
By leveraging our models, we’re providing local decision-makers with the information they need to direct resources more effectively.
New Team Members
Greg Cohan, MD joined us in November as our Director of Product Development. Prior to becoming a physician, Greg worked as a software engineer; his role on our team allows him to leverage his experience in both technology and medicine. Greg is spearheading the creation of the minimal viable product (MVP) of the Apriqot platform. Greg’s favorite winter activity is rock climbing and he recently enjoyed reading The Secret Life of Church Ladies by Deesha Philyaw.
Muskan Khandelwal is our newest Northeastern modeling co-op. She is stepping into the role of Machine Learning Engineer and will continue to advance the work started by our previous co-ops, Xinyan and Orijeet. Muskan is pursuing a Master’s in Data Science at the Boston Northeastern campus. Muskan’s favorite winter activity is sipping hot chocolate and game nights. She has been enjoying finally getting around to watching Game of Thrones.
Shashwath Udaya Kumar is joining our team to serve as a part-time software engineer. Shashwath is currently pursuing a Master’s in Computer Science at the Roux Institute. He works closely with Greg to support the development of our MVP. Shashwath’s favorite winter activity is sleeping and he recently enjoyed watching Arcane.
Press, Presentations, and Celebrations
Featured in
Roux Institute
Entrepreneurship Article
We were featured in a recent Roux Institute article, spotlighting our role in driving innovation and supporting public health transformation.
Read the Article
Presented at the Maine
Public Health Association (MPHA) Conference
We presented groundbreaking research on Alzheimer’s Disease and related dementia at this year’s MPHA conference in Portland, Maine. This presentation showcased our work to downscale geographic estimates of ADRD in Maine and provided valuable insights for local public health planning.
Received
MTI Range III
Grant Funding
We’re proud to announce that Apriqot was awarded a $50,000 MTI Range III grant. This grant supports the development of our prototype into a minimally viable product (MVP), a critical step toward launching our software as a service (SaaS) platform.
Looking Ahead
As we head into 2025, Apriqot’s focus is clear—scaling our product, expanding our team, and driving public health transformation. Stay tuned for more updates as we continue to grow and innovate.
​
​
Thank you for being part of our journey to transform public health with data-driven solutions.